Fresh Tracks Therapeutics Inc (FRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 8,006 | 6,943 | 404 | 1,822 | 7,917 |
| Gross Profit | 8,006 | 6,943 | 404 | 1,822 | 7,917 |
| Operating Expenses | 14,366 | 28,477 | 40,648 | 22,798 | 32,385 |
| Operating Income | -6,360 | -21,534 | -40,244 | -20,976 | -24,468 |
| Interest Expense | 5 | 9 | 69 | 0 | 2,096 |
| Other Income | 671 | 441 | 839 | 63 | 2,687 |
| Pre-tax Income | -5,694 | -21,102 | -39,474 | -20,913 | -23,877 |
| Net Income Continuous | -5,694 | -21,102 | -39,474 | -20,913 | -23,877 |
| Net Income | $-5,694 | $-21,102 | $-39,474 | $-20,913 | $-23,877 |
| EPS Basic Total Ops | -1.06 | -7.51 | -22.12 | -38.29 | -202.70 |
| EPS Basic Continuous Ops | -1.06 | -7.52 | -22.12 | -38.43 | -355.79 |
| EPS Diluted Total Ops | -1.06 | -7.51 | -22.12 | -38.29 | -202.70 |
| EPS Diluted Continuous Ops | -1.06 | -7.52 | -22.12 | -38.43 | -355.79 |
| EPS Diluted Before Non-Recurring Items | -1.06 | -7.51 | -22.07 | -38.29 | -230.18 |
| EBITDA(a) | $-6,319 | $-21,504 | $-40,222 | $-20,966 | $-22,865 |